CA2369454A1 - Nouvelles utilisations de la proteine ox2 de mammifere et reactifs associes - Google Patents
Nouvelles utilisations de la proteine ox2 de mammifere et reactifs associes Download PDFInfo
- Publication number
- CA2369454A1 CA2369454A1 CA002369454A CA2369454A CA2369454A1 CA 2369454 A1 CA2369454 A1 CA 2369454A1 CA 002369454 A CA002369454 A CA 002369454A CA 2369454 A CA2369454 A CA 2369454A CA 2369454 A1 CA2369454 A1 CA 2369454A1
- Authority
- CA
- Canada
- Prior art keywords
- mammalian
- tissue
- protein
- antagonist
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1891—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
Abstract
On décrit des compositions et des procédés dans lesquels on utilise un ligand OX2 de mammifère pour traiter une condition pathologique anormale chez un individu. Les procédés consistent à administrer une quantité thérapeutiquement efficace de OX2 seul ou bien en combinaison avec d'autres réactifs thérapeutiques; ou un antagoniste OX2.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29082599A | 1999-04-13 | 1999-04-13 | |
US09/290,825 | 1999-04-13 | ||
PCT/US2000/009719 WO2000061171A2 (fr) | 1999-04-13 | 2000-04-12 | Nouvelles utilisations de la proteine ox2 de mammifere et reactifs associes |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2369454A1 true CA2369454A1 (fr) | 2000-10-19 |
Family
ID=23117713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002369454A Abandoned CA2369454A1 (fr) | 1999-04-13 | 2000-04-12 | Nouvelles utilisations de la proteine ox2 de mammifere et reactifs associes |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1171154A2 (fr) |
JP (1) | JP2002541210A (fr) |
AR (1) | AR023464A1 (fr) |
AU (1) | AU4341300A (fr) |
CA (1) | CA2369454A1 (fr) |
MX (1) | MXPA01010480A (fr) |
WO (1) | WO2000061171A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1439857B1 (fr) | 2001-10-12 | 2009-02-25 | Schering Corporation | UTILISATION D'ANTICORPS BISPECIFIQUES RECONNAISSANT LE RECEPTEUR D'ACTIVATION FcEpsilon RI ET LE RECEPTEUR D'INHIBITION OX2Ra (CD200Ra) POUR REGULER DES REPONSES IMMUNITAIRES |
GB201608197D0 (en) | 2016-05-10 | 2016-06-22 | Ducentis Biotherapeutics Ltd | Novel proteins |
GB202115803D0 (en) | 2021-11-03 | 2021-12-15 | Ducentis Biotherapeutics Ltd | Novel proteins |
WO2023214388A1 (fr) | 2022-05-06 | 2023-11-09 | Ducentis Biotherapeutics Limited | Nouvelles protéines de fusion cd200 |
WO2023214387A1 (fr) | 2022-05-06 | 2023-11-09 | Ducentis Biotherapeutics Limited | Nouvelles protéines de fusion cd200 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5859208A (en) * | 1988-07-06 | 1999-01-12 | Fiddes; John C. | Human basic fibroblast growth factor analog |
WO1997021450A1 (fr) * | 1995-12-08 | 1997-06-19 | Brigham And Women's Hospital, Inc. | Molecule costimulante ox-2 |
US5753218A (en) * | 1996-05-03 | 1998-05-19 | Schering Corporation | Method for treating inflammation |
ATE319825T1 (de) * | 1997-11-07 | 2006-03-15 | Trillium Therapeutics Inc | Verfahren und zusammensetzungen zur immunomodulation |
-
2000
- 2000-04-12 CA CA002369454A patent/CA2369454A1/fr not_active Abandoned
- 2000-04-12 JP JP2000610503A patent/JP2002541210A/ja not_active Withdrawn
- 2000-04-12 AU AU43413/00A patent/AU4341300A/en not_active Abandoned
- 2000-04-12 AR ARP000101685A patent/AR023464A1/es unknown
- 2000-04-12 MX MXPA01010480A patent/MXPA01010480A/es unknown
- 2000-04-12 WO PCT/US2000/009719 patent/WO2000061171A2/fr not_active Application Discontinuation
- 2000-04-12 EP EP00923257A patent/EP1171154A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AR023464A1 (es) | 2002-09-04 |
AU4341300A (en) | 2000-11-14 |
EP1171154A2 (fr) | 2002-01-16 |
JP2002541210A (ja) | 2002-12-03 |
WO2000061171A3 (fr) | 2001-01-25 |
WO2000061171A2 (fr) | 2000-10-19 |
WO2000061171A9 (fr) | 2002-01-03 |
MXPA01010480A (es) | 2002-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020192215A1 (en) | Novel uses of mammalian OX2 protein and related reagents | |
ES2149149T3 (es) | Proteinas de union a interleuquina-18, su preparacion y uso. | |
Girard et al. | Cloning from purified high endothelial venule cells of hevin, a close relative of the antiadhesive extracellular matrix protein SPARC | |
US20120141456A1 (en) | Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System | |
EP1121454A1 (fr) | Nouvelle proteine extracellulaire liant le peptide rage (en-rage), et utilisations correspondantes | |
US6555340B1 (en) | Nucleic acid encoding bovine extracellular rage binding protein (en-rage) | |
WO2007098283A2 (fr) | Utilisation d'antagonistes de molécules complexes du récepteur maif (macrophage migration-inhibitory factors) et de facteurs neurotrophiques pour traiter des maladies et des troubles neurologiques | |
EP1326974B1 (fr) | Procedes relatifs a l'utilisation de polypeptide lie a l'interleukine 17 (il-17) humaine pour le traitement de maladies- | |
JP2007319163A (ja) | Ox2レセプターホモログ | |
US20020138860A1 (en) | Novel uses of mammalian CCR6 receptors and related reagents | |
US20030215442A1 (en) | Methods and compositions for the treatment or prevention of immune disorders using combination therapy | |
NZ238659A (en) | Mast cell growth factor, recombinant production and isolated sequences | |
CA2369454A1 (fr) | Nouvelles utilisations de la proteine ox2 de mammifere et reactifs associes | |
US20150329638A1 (en) | Use of DR6 Antagonists to Improve Motor Neuron Disease | |
CA2235951C (fr) | Nouveaux emplois du ctla-8 de mammifere et reactifs associes | |
KR20000075732A (ko) | 임파구의 활성화 억제제 | |
JP4482235B2 (ja) | 哺乳動物ランゲルハンス細胞抗原に対する抗体およびそれらの使用 | |
Hasegawa et al. | Monoclonal antibodies to epitope of CD45R (B220) inhibit interleukin 4-mediated B cell proliferation and differentiation | |
AU705281B2 (en) | Secreted human fas antigen | |
WO1996020206A9 (fr) | Antigene du fas secrete par l'homme | |
US6063372A (en) | Uses of mammalian CTLA-8 and related reagents | |
WO1995002611A1 (fr) | Proteine de surface cellulaire presente sur les cellules tueuses naturelles appelee dx1 | |
US20060165689A1 (en) | Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 | |
Sytwu | T cell activation, apoptosis, and autoimmune disease | |
WO2005118637A1 (fr) | Traitement d'etats inflammatoires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |